Industry News
Bacteria genomes hold blueprints for anticancer drugs
Scientists have 'mined' the information stored in bacteria genomes, which they suggest hold the blueprints for new, effective cancer-targeting compounds. [ + ]
New protein functions uncovered
Scientists have developed a new approach to identify important undiscovered functions of proteins. [ + ]
Computer algorithms identify cancer from tissue images
Artificially intelligent computer algorithms have been found to equal human pathologists in detecting metastases of breast cancer in lymph nodes. [ + ]
Nutraceuticals market growing despite regulatory challenges
Nutraceuticals are expanding into new territories as the need for new therapies increases, according to GBI Research. [ + ]
Protein programs killer T cells to migrate to tumour sites
Researchers have discovered that a protein called Runx3 programs killer T cells to establish residence in tumours and infection sites. [ + ]
Personalised seizure prediction made possible with AI
Australian epilepsy researchers have used a mobile, brain-inspired processor to bring personalised seizure prediction a step closer to a reality. [ + ]
Merck signs global distribution agreement with Avanti Polar Lipids
Merck has entered into an agreement with Avanti Polar Lipids to be the exclusive multinational distributor of the latter's research lipids portfolio outside of the United States. [ + ]
Nearly 40% of Australian cancer deaths are potentially preventable
Queensland researchers have found that 38% of cancer deaths in Australia, or 16,700 each year, could potentially be avoided — mostly through lifestyle changes. [ + ]
Geneticist and angel investor Jay Hetzel appointed as UniQuest chairman
Scientist and angel investor Dr Jay Hetzel has been appointed chairman of UniQuest, The University of Queensland's commercialisation company. [ + ]
Light-activated glue seals wounds in 60 seconds
Australian scientists have invented a gel that seals wounds and stops bleeding — both internally and externally — within 60 seconds. It sends signals to the body to start repairing the wound — at twice the regular speed. [ + ]
Technology partnership to treat ANSTO's radioactive waste
ANSTO and Swedish company Quintus Technologies have formed a new technology partnership that will play a crucial role in treating waste arising from nuclear medicine production. [ + ]
Gene editing — one reagent doesn't fit all
Person-to-person genetic differences may undercut the efficacy of the gene editing process or, in more rare cases, cause a potentially dangerous off-target effect, warn researchers. [ + ]
In vitro diagnostics market to reach US$69 billion in 2024: GlobalData
The overall market value of in vitro diagnostics stands at US$52 billion this year and is projected to grow at a compound annual growth rate of 4.2% to US$69 billion in 2024, according to GlobalData. [ + ]
Engineering yeast to create protein pharmaceuticals
Researchers, headed by Professor Jens Nielsen at Chalmers University of Technology, have successfully mapped out the complex metabolism of yeast cells. [ + ]
Tumour-suppressive protein patrols metastatis sites
Belgian researchers have labelled the protein Caveolin-1 as a high-potential pursuit in the fight against cancer, describing the 'anti-metastatic surveillance' role of the protein for the first time. [ + ]
